These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10570349)

  • 1. Irinotecan (CPT-11) induced colitis: report of a case and review of Food and Drug Administration MEDWATCH reporting.
    Sears S; McNally P; Bachinski MS; Avery R
    Gastrointest Endosc; 1999 Dec; 50(6):841-4. PubMed ID: 10570349
    [No Abstract]   [Full Text] [Related]  

  • 2. Central nervous system toxicity induced by irinotecan.
    Hamberg P; Donders RC; ten Bokkel Huinink D
    J Natl Cancer Inst; 2006 Feb; 98(3):219. PubMed ID: 16449682
    [No Abstract]   [Full Text] [Related]  

  • 3. Diffuse mucosal damage in the large intestine associated with Irinotecan (CPT-11).
    Duong Van Huyen JP; Bloch F; Attar A; Levoir D; Kreft C; Molina T; Bruneval P
    Dig Dis Sci; 1998 Dec; 43(12):2649-51. PubMed ID: 9881496
    [No Abstract]   [Full Text] [Related]  

  • 4. An autopsy case of acute pulmonary toxicity related to irinotecan.
    Ruiz-Casado A; Castellano V; Moreno F
    Clin Transl Oncol; 2008 Sep; 10(9):597-8. PubMed ID: 18796380
    [No Abstract]   [Full Text] [Related]  

  • 5. [Severe acute cytomegalovirus colitis after administration of irinotecan and raltitrexed chemotherapy].
    Dumortier J; Villarejo J; Lapalus MG; Vochelle V; Beatrix O; Scoazec JY; Lombard-Bohas C
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):347-8. PubMed ID: 12700527
    [No Abstract]   [Full Text] [Related]  

  • 6. Irinotecan-induced dysarthria.
    Baz DV; Bofill JS; Nogueira JA
    J Natl Cancer Inst; 2001 Sep; 93(18):1419-20. PubMed ID: 11562394
    [No Abstract]   [Full Text] [Related]  

  • 7. Phlebitis due to irinotecan.
    Tas F; Karagol H; Karadeniz A; Topuz E
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):167. PubMed ID: 12801060
    [No Abstract]   [Full Text] [Related]  

  • 8. Dysarthria induced by irinotecan in a patient with colorectal cancer.
    Lee KA; Kang HW; Ahn JH; Suk HJ; Kim H
    Am J Health Syst Pharm; 2013 Jul; 70(13):1140-3. PubMed ID: 23784161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of hepatic metastasis from rectal carcinoma successfully treated with pharmacokinetic modulating chemotherapy (PMC)-CPT-11 therapy].
    Matsusaka S; Oriyama T; Okada T; Chang W; Maeda S; Kondo Y; Kosaka H
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):461-4. PubMed ID: 11915740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of metastatic liver tumor of colorectal cancer responding to low-dose CPT-11 chemotherapy].
    Funahashi K; Miki T; Koike J; Washizawa N; Shibata Y; Matsumoto H; Tokuyama T; Ryu M; Shiokawa H; Goto T; Teramoto T
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):419-21. PubMed ID: 12669404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irinotecan-induced colitis.
    Sandmeier D; Chaubert P; Bouzourene H
    Int J Surg Pathol; 2005 Apr; 13(2):215-8. PubMed ID: 15864388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group].
    Futatsuki K; Wakui A; Nakao I; Sakata Y; Kambe M; Shimada Y; Yoshino M; Taguchi T; Ogawa N
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1033-8. PubMed ID: 8210254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dysarthria during irinotecan administration].
    Ceccaldi B; Kara F; Mommeja-Marin H; Bègue M; Saint Blancard P; Le Marec E; Hauteville D
    Rev Med Interne; 2002 Nov; 23(11):950-1. PubMed ID: 12481397
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicity of irinotecan (CPT-11) and hepato-renal dysfunction.
    Ong SY; Clarke SJ; Bishop J; Dodds HM; Rivory LP
    Anticancer Drugs; 2001 Aug; 12(7):619-25. PubMed ID: 11487719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
    Bhutiani N; Akinwande O; Martin RC
    World J Surg; 2016 May; 40(5):1178-90. PubMed ID: 26711640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly irinotecan in a patient with metastatic colorectal cancer on hemodialysis due to chronic renal failure.
    Stemmler J; Weise A; Hacker U; Heinemann V; Schalhorn A
    Onkologie; 2002 Feb; 25(1):60-3. PubMed ID: 11893885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case report of poorly-differentiated adenocarcinoma in sigmoid colon cancer with liver and pulmonary metastasis responding to TS-1 and CPT-11].
    Nakao K; Tsunoda A; Amagasa H; Suzuki N; Yamazaki K; Kusano M
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):109-12. PubMed ID: 16410709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11).
    Palmer RD; Williams DM
    Med Pediatr Oncol; 2003 Jul; 41(1):78-80. PubMed ID: 12764754
    [No Abstract]   [Full Text] [Related]  

  • 19. Bradycardia associated with drug-eluting beads loaded with irinotecan (DEBIRI) infusion for colorectal liver metastases.
    Pua U
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):864-6. PubMed ID: 22722719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of docetaxel-irinotecan combination in advanced pancreatic cancer.
    Kurtz JE; Négrier S; Husseini F; Limacher JM; Borel C; Wagner JP; Prévot G; Bergerat JP; Dufour P
    Hepatogastroenterology; 2003; 50(50):567-70. PubMed ID: 12749274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.